Live
- AI Model Detects Residual Brain Tumors in 10 Seconds, Offers Real-Time Surgical Guidance
- Reliance and Disney Complete JV Deal to Strengthen Entertainment Presence in India
- UP Govt Agrees to Protesters’ Demand, PCS Exam to Be Held in One Day
- Trump’s Social Security Tax Promise Faces Hurdles: What Retirees Need to Know
- Strict Action Needed Against Attacks on Government Employees - Retired Employees
- Hyundai Motor India Limited Announces 2024 Edition of ‘Hyundai Always Around’ Campaign
- Minister for Environment, Forests, and Endowments Celebrates Karthika Pournami and Guru Nanak Jayanti
- World Quality Day: Hindustan Zinc Reaffirms Commitment to Superior Product Quality & Innovation
- Grand Kartika Purnima Celebrations at Nagar Kurnool’s Saraswati Shishu Mandir
- Children’s day celebrations, Karnataka remnisences on Nehru’s contributions
Dr Reddy's launches heartburn capsules in US market
Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food and Drug Administration (USFDA), Dr Reddy's said in a BSE filing.
"We are pleased to continue to expand our antacids and PPI portfolio for our customers," Dr Reddy's Laboratories Senior Vice President and Head of US OTC and Specialty Rx Divisions Milan Kalawadia said.
The company's product is over-the-counter store-brand equivalent to Takeda Pharmaceuticals North America Inc's Prevacid 24HR capsules, the company said.
